black box warning for glp 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Are GLP-1 Medications Safe in

The analysis found women who received 1020 mg equol or up to 200 mg isoflavones (equol producers only) experienced reductions in menopausal hot flashes

Semaglutide GLP-1 was originally developed to treat type 2 diabetes, but it has also proven highly effective for weight management

Many customers are coming in with a clearer plan and less interest in filling the cart just because. In real terms, that can look like a shopper who used to grab a family-size snack now choosing a single-serve option, or someone skipping an entire aisle and heading straight for a few specific items

Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history

A laboratory analysis published in Expert Opinion on Drug Safety on April 30, 2026, examined samples of compounded tirzepatide mixed with B12 obtained from various sources in the U.S

Insulin use in type 2 diabetes and the risk of dementia: a comparative population-based cohort study